Darbepoetin Alfa

Darbepoetin Alfa is a hyperglycosylated analogue of recombinant human erythropoietin (rhEPO) with a longer half-life than epoetin alfa. It stimulates erythropoiesis and is used for anemia associated with chronic kidney disease and chemotherapy-induced anemia. Mediocon Inc supplies pharmaceutical-grade Darbepoetin Alfa for bulk pharma manufacturing.

Key Features

• Analgesic, antipyretic & anti-inflammatory
• USP/BP/IP compliant quality
• Widely used in cardiovascular therapy
• Suitable for tablet and effervescent formulations

Applications

• Anemia of chronic kidney disease (CKD)
• Chemotherapy-induced anemia (CIA)
• Pre-dialysis and dialysis patients
• Biologic injectable formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings